Funtleyder Leslie D.

Officer, Director at Applied Therapeutics, Inc.

Sold, on record
$5.1M
Dollars the filings state
Form 4 sales
13
Latest Mar 4, 2025
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Applied Therapeutics, Inc.Unusual
    Jun 25, 2020 2020

    Sold 20,000 shares at $42.43 ($849k)

    Funtleyder Leslie D., Director

    Sold 53.8% of holdings ($1.6M position)17,148 shares left1.3x usual sizeFiling

  2. 2 Form 4 sale Applied Therapeutics, Inc.Unusual
    Aug 24, 2020 +60 days

    Sold 13,539 shares at $23.42 ($317k)

    Funtleyder Leslie D., Director

    Sold 36.4% of holdings ($870k position)23,609 shares left0.8x usual sizeFiling

  3. 3 Form 4 sale Applied Therapeutics, Inc.Unusual
    Oct 2, 2020 +39 days

    Sold 30,000 shares at $20.07 ($602k)

    Funtleyder Leslie D., Director

    Sold 63.6% of holdings ($946k position)17,148 shares left2x usual sizeFiling

  4. 4 Form 4 sale Applied Therapeutics, Inc.No plan
    Mar 14, 2024 +1259 days

    Sold 28,727 shares at $5.39 ($155k)

    Funtleyder Leslie D., Chief Financial Officer

    No 10b5-1 planSold 8.5% of holdings ($1.8M position)308,421 shares leftFirst sale on recordFiling

  5. 5 Form 4 sale Applied Therapeutics, Inc.No plan
    Jun 6, 2024 +84 days

    Sold 16,980 shares at $4.32 ($73k)

    Funtleyder Leslie D., Chief Financial Officer

    No 10b5-1 planSold 5.5% of holdings ($1.3M position)291,441 shares leftFiling

  6. 6 Form 4 sale Applied Therapeutics, Inc.No plan
    Aug 22, 2024 +77 days

    Sold 13,530 shares at $5.83 ($79k)

    Funtleyder Leslie D., Chief Financial Officer

    No 10b5-1 planSold 4.6% of holdings ($1.7M position)277,911 shares leftFiling

  7. 7 Form 4 sale Applied Therapeutics, Inc.No plan
    Feb 6, 2025 +168 days

    Sold 22,950 shares at $0.61 ($14k)

    Funtleyder Leslie D., Officer, Director

    No 10b5-1 planSold 5.4% of holdings ($261k position)404,961 shares left1.4x usual sizeFiling

  8. 8 Form 4 sale Applied Therapeutics, Inc.No plan
    Mar 4, 2025 +26 days

    Sold 14,502 shares at $0.44 ($6k)

    Funtleyder Leslie D., Officer, Director

    No 10b5-1 planSold 3.6% of holdings ($178k position)390,459 shares left0.7x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (13)

Form 144 notices and Form 4 sales by Funtleyder Leslie D.
Source
Mar 4, 2025Mar 6, 2025Applied Therapeutics, Inc.Officer, DirectorForm 4 sale14,502$6k3.6%No planSEC
Feb 6, 2025Feb 7, 2025Applied Therapeutics, Inc.Officer, DirectorForm 4 sale22,950$14k5.4%No planSEC
Aug 22, 2024Aug 23, 2024Applied Therapeutics, Inc.Chief Financial OfficerForm 4 sale13,530$79k4.6%No planSEC
Jun 6, 2024Jun 10, 2024Applied Therapeutics, Inc.Chief Financial OfficerForm 4 sale16,980$73k5.5%No planSEC
Mar 14, 2024Mar 18, 2024Applied Therapeutics, Inc.Chief Financial OfficerForm 4 sale28,727$155k8.5%No planSEC
Oct 2, 2020Oct 5, 2020Applied Therapeutics, Inc.DirectorForm 4 sale30,000$602k63.6%UnusualSEC
Aug 24, 2020Aug 25, 2020Applied Therapeutics, Inc.DirectorForm 4 sale13,539$317k36.4%UnusualSEC
Jun 25, 2020Jun 25, 2020Applied Therapeutics, Inc.DirectorForm 4 sale20,000$849k53.8%UnusualSEC
Jun 18, 2020Jun 22, 2020Applied Therapeutics, Inc.DirectorForm 4 sale7,498$340k30.4%UnusualSEC
Jun 17, 2020Jun 17, 2020Applied Therapeutics, Inc.DirectorForm 4 sale9,502$421k27.8%UnusualSEC
Jun 10, 2020Jun 10, 2020Applied Therapeutics, Inc.DirectorForm 4 sale17,000$745k49.8%UnusualSEC
Jun 4, 2020Jun 4, 2020Applied Therapeutics, Inc.DirectorForm 4 sale15,000$675k46.7%UnusualSEC
May 29, 2020Jun 1, 2020Applied Therapeutics, Inc.DirectorForm 4 sale18,453$835k51.8%UnusualSEC